Bliss GVS Pharma Ltd.
NSE: BLISSGVS | BSE: 506197
₹617.20
₹-30.30
(-4.68%)
As on 02-Nov-2026IST
Market cap
₹6,560 Cr
Revenue (TTM)
₹1,074 Cr
P/E Ratio
40.7
P/B Ratio
5.1
Div. Yield
0.2 %
Quality Score
3/10
Growth Score
7/10
Valuation Score
2/10
Momentum Score
10/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹161 Cr
-
ROE
12.1 %
-
ROCE
17.4 %
-
Industry P/E
37.34
-
EV/EBITDA
22.6
-
Debt to Equity
0
-
Book Value
₹121.3
-
EPS
₹15.3
-
Face value
1
-
Shares outstanding
106,383,972
10 Years Aggregate
CFO
₹974.97 Cr
EBITDA
₹1,449.68 Cr
Net Profit
₹903.66 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Bliss GVS Pharma
| 277.7 | -9.7 | 32.5 | 293.5 | 94.4 | 41.8 | 14.4 |
|
BSE Healthcare
| 15.8 | 0.7 | -1.0 | 12.9 | 22.5 | 14.7 | 11.9 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Bliss GVS Pharma
| -7.9 | 31.9 | 72.2 | -30.2 | -48.8 | 36.7 | -7.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Bliss GVS Pharma
|
617.2 | 6,560.2 | 1,074.2 | 166.5 | 18.5 | 13.1 | 40.7 | 5.1 |
| 2,171.1 | 13,280.6 | 1,559.1 | 206.6 | 18.4 | 28.5 | 64.2 | 16.5 | |
| 1,160.2 | 16,138.8 | 3,329.6 | 720.8 | 26.3 | 18.9 | 22.8 | 3.9 | |
| 381.1 | 6,205.5 | 2,289.3 | 313.3 | 13.4 | 12.8 | 19.8 | 2.3 | |
| 216.3 | 1,424.9 | 300.8 | 45.5 | 17.6 | 18.2 | 31.3 | 5.8 | |
| 5,828.0 | 9,652.8 | 1,490.5 | 379.9 | 31.8 | 60.2 | 25.4 | 15.7 | |
| 934.5 | 2,079.1 | 301.8 | 42.9 | 21.5 | 12.8 | 48.5 | 6.0 | |
| 3,349.8 | 7,710.1 | 1,821.5 | 364.5 | 26.0 | 46.3 | 21.2 | 8.2 | |
| 1,036.9 | 9,566.5 | 5,213.3 | 636.0 | 14.2 | 17.7 | 15.5 | 2.8 | |
| 1,300.5 | 1,728.8 | 837.3 | 121.7 | 17.7 | 17.8 | 14.2 | 2.5 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Bliss GVS Pharma
Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally. The company offers anti-diabetic, anti-infective, anti-inflammatory, antifungal, antihemorrhoidal,... antimalarial, antiseptic, cardiovascular, dermatological, gastrointestinal, gynaecology, neoro/cns, ophthalmic, otc drugs, respiratory, urology, and supplementary drug products, as well as engages in pain management services. It exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India. Read more
-
Incorporated
1984
-
Chairman
Nandkumar chodankar
-
Managing Director
--
-
Headquarters
Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Bliss GVS Pharma
What is the current share price of Bliss GVS Pharma Ltd Today?
The share price of Bliss GVS Pharma Ltd is ₹617.20 (NSE) and ₹616.65 (BSE) as of 02-Nov-2026 IST. Bliss GVS Pharma Ltd has given a return of 94.41% in the last 3 years.
What is the current PB & PE ratio of Bliss GVS Pharma Ltd?
The P/E ratio of Bliss GVS Pharma Ltd is 40.70 times as on 02-Nov-2026, a 9 premium to its peers’ median range of 37.34 times.
The P/B ratio of Bliss GVS Pharma Ltd is 5.08 times as on 02-Nov-2026, a 6 premium to its peers’ median range of 4.78 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
17.66 |
1.93 |
2025 |
14.69 |
1.19 |
2024 |
15.63 |
1.23 |
2023 |
10.47 |
0.85 |
2022 |
53.04 |
0.99 |
What is the 52 Week High and Low of Bliss GVS Pharma Ltd?
The 52-week high and low of Bliss GVS Pharma Ltd are Rs 739.90 and Rs 118.00 as of 02-Nov-2026.
What is the market cap of Bliss GVS Pharma Ltd?
Bliss GVS Pharma Ltd has a market capitalisation of ₹ 6,560 Cr as on 02-Nov-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Bliss GVS Pharma Ltd?
Before investing in Bliss GVS Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.